HIGHLIGHTS
- who: Tsuguhiro Matsumoto from the (UNIVERSITY) have published the research: Use of remimazolam in living donor liver transplantation: a case report, in the Journal: (JOURNAL)
- what: The authors report the use of remimazolam for the anesthetic management of living donor liver transplantation in a patient with endstage liver disease who had a family history of malignant hyperthermia.
SUMMARY
Remimazolam, an ester-based, ultra-short-acting benzodiazepine is rapidly hydrolyzed by tissue esterases (mainly liver carboxylesterase) to an inactive metabolite. The effects of remimazolam on lowering blood pressure are milder than propofol . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.